↓ Skip to main content

Inflammation as a Risk Factor in Cardiotoxicity: An Important Consideration for Screening During Drug Development

Overview of attention for article published in Frontiers in Pharmacology, April 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inflammation as a Risk Factor in Cardiotoxicity: An Important Consideration for Screening During Drug Development
Published in
Frontiers in Pharmacology, April 2021
DOI 10.3389/fphar.2021.598549
Pubmed ID
Authors

Chiara Campana, Rafael Dariolli, Mohamed Boutjdir, Eric A. Sobie

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 22%
Student > Bachelor 3 13%
Other 2 9%
Researcher 2 9%
Professor 2 9%
Other 1 4%
Unknown 8 35%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 17%
Engineering 3 13%
Medicine and Dentistry 2 9%
Unspecified 1 4%
Immunology and Microbiology 1 4%
Other 3 13%
Unknown 9 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 May 2023.
All research outputs
#7,633,360
of 23,920,246 outputs
Outputs from Frontiers in Pharmacology
#3,337
of 17,600 outputs
Outputs of similar age
#163,310
of 436,416 outputs
Outputs of similar age from Frontiers in Pharmacology
#181
of 869 outputs
Altmetric has tracked 23,920,246 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 17,600 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,416 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 869 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.